Van Hulzen Asset Management LLC Takes Position in HealthEquity, Inc. $HQY

Van Hulzen Asset Management LLC purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 5,000 shares of the company’s stock, valued at approximately $452,000.

Other large investors also recently bought and sold shares of the company. Ranger Investment Management L.P. acquired a new stake in HealthEquity in the second quarter valued at approximately $28,835,000. Sanctuary Advisors LLC acquired a new position in shares of HealthEquity during the 2nd quarter worth approximately $605,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of HealthEquity during the 2nd quarter valued at approximately $1,836,000. Elevation Point Wealth Partners LLC acquired a new stake in HealthEquity in the 2nd quarter valued at $589,000. Finally, Commerce Bank acquired a new stake in HealthEquity in the 2nd quarter valued at $633,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Down 0.0%

Shares of HQY opened at $105.39 on Wednesday. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The stock has a market cap of $8.81 billion, a PE ratio of 39.47, a price-to-earnings-growth ratio of 1.77 and a beta of 0.21. The firm’s fifty day moving average is $97.41 and its two-hundred day moving average is $87.53. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Citizens Jmp upped their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research note on Monday, June 1st. Barrington Research restated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Finally, Royal Bank Of Canada raised their price target on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research note on Wednesday, June 3rd. Eleven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares in the company, valued at approximately $4,963,180. This represents a 4.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 17,905 shares of company stock valued at $1,651,280. Corporate insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.